You are here:
  1. Homepage
  2. Our products
  3. Autoinjectors
  4. Molly® 2.25

Molly® 2.25

Molly® 2.25 is a large-volume variant of the Molly autoinjector to accommodate larger-volume biologics. Featuring the same easy-to-use, 2-step operation, it inherited the modular platform development model to support high-volume manufacturing, faster development, and flexible design for unique branding needs. 

<p>Molly 2.5 ml autoinjector with the cap off for SHL Medical</p>

Meet Molly® 2.25

Molly_2.25_instruction_1

Specifications

Viscosity
low
Volume
2.25 ml
Device type
Disposable autoinjector
Primary container
Pre-Filled Syringe
Route of administration
Subcutaneous
Connectivity
Yes
Dosage type
Fiexd | Full contents
Activation method
Needle cover
Injection feedback
Audible click, viewing window
Customization
Yes

Unparalleled track record

We work with 12+ pharmaceutical companies to commercialize our Molly® and Molly® 2.25 autoinjectors. 17 combination products have been approved so far, including the world’s first large-volume autoinjector with a ≥ 2.0 mL fill. 

Rheumatoid arthritis

The first Molly® autoinjector (1.0 mL) was launched in 2016 to treat moderate to severe rheumatoid arthritis.

Migraine

The 1mL Molly® autoinjector, designed for a medication targeting acute migraine headaches, was launched in 2016.

Atopic dermatitis

Molly® and Molly® 2.25 were introduced in 2020 as treatments for asthma and atopic dermatitis.

Diabetes

In 2020, the Molly® autoinjector was launched as a self-injection solution for diabetes patients, intended to work alongside insulin treatment.

Hypoglycemia

In 2019, we launched the Molly autoinjector with a 1mL pre-filled syringe to treat severe hypoglycemia (very low blood sugar) in adults and children aged 2 years and older with diabetes.

Weight management

SHL Medical's Molly® autoinjector (1 mL version), launched in 2021, has significantly influenced patient care and the pharmaceutical industry through its role in effective weight-loss treatments.

Want to check if Molly® is suitable for your molecular entity? Get in touch.

Molly 2.25 vertical

Modular platform technology

Molly®'s modular autoinjector platform technology takes a unique approach to platform design by integrating modules into its ecosystem. These modules refer to the Molly device design and core technology, manufacturing infrastructures, and add-on features that respond to digital health and sustainability imperatives, as well as the ever-changing market landscape.

Modular platform technology

Molly®'s modular autoinjector platform technology takes a unique approach to platform design by integrating modules into its ecosystem. These modules refer to the Molly device design and core technology, manufacturing infrastructures, and add-on features that respond to digital health and sustainability imperatives, as well as the ever-changing market landscape.
Tooling-molding-carving

Other variations

molly-1.0-product-card
Molly®

Molly®

Viscosity
Volume

Built on a modular platform technology, Molly® is designed to meet the evolving requirements of future autoinjectors, such as introducing unique designs for branding and user requirements, as well as high-volume manufacturing.

 

The Molly autoinjector is designed with an ergonomic body and a flange-shaped anti-roll cap for an easier handling experience.
molly-connected-cap-product-card
Molly®
Connected Cap

Molly®
Connected Cap

Upon removal from the Molly® device, the Connected Cap becomes active, allowing timestamped data to be relayed through a smart data transmission hub and to the cloud.